Blood Flow and Glucose Metabolism Dissociation in the Putamen Is Predictive of Levodopa Induced Dyskinesia in Parkinson's Disease Patients

Background: The forefront treatment of Parkinson's disease (PD) is Levodopa. When patients are treated with Levodopa cerebral blood flow is increased while cerebral metabolic rate is decreased in key subcortical regions including the putamen. This phenomenon is especially pronounced in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Aljuaid, Maram, Booth, Samuel, Hobson, Douglas E., Borys, Andrew, Williams, Kelly, Katako, Audrey, Ryner, Lawrence, Goertzen, Andrew L., Ko, Ji Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881455/
https://www.ncbi.nlm.nih.gov/pubmed/31824400
http://dx.doi.org/10.3389/fneur.2019.01217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881455/
https://www.ncbi.nlm.nih.gov/pubmed/31824400
http://dx.doi.org/10.3389/fneur.2019.01217

Ejemplares similares